EdgarLookup

AleAnna, Inc. — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that AleAnna, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Annual Quarterly Insiders
13.6%
Profit Margin
Net income ÷ revenue
3.4%
Return on Assets
Net income ÷ assets
-0.28x
Debt-to-Equity
Total liabilities ÷ equity
+1663%
Revenue Growth
Year over year

Revenue

Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $25.04M Mar 31, 2026
FY2025 Dec 31, 2024 $1.42M Mar 31, 2026

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2023 Dec 31, 2023 $3.42M Apr 1, 2024
FY2023 Dec 31, 2022 $1.50M Apr 1, 2024
FY2022 Dec 31, 2021 ($483.0K) Sep 13, 2023

Operating Income

Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $2.90M Mar 31, 2026
FY2025 Dec 31, 2024 ($14.55M) Mar 31, 2026
FY2024 Dec 31, 2023 ($5.77M) Mar 31, 2025
FY2023 Dec 31, 2022 ($1.45M) Apr 1, 2024
FY2022 Dec 31, 2021 ($139.5K) Sep 13, 2023

Operating Cash Flow

Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $10.16M Mar 31, 2026
FY2025 Dec 31, 2024 ($16.90M) Mar 31, 2026
FY2024 Dec 31, 2023 ($5.75M) Mar 31, 2025
FY2023 Dec 31, 2022 ($413.9K) Apr 1, 2024
FY2022 Dec 31, 2021 ($1.10M) Sep 13, 2023

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $101.30M Mar 31, 2026
FY2025 Dec 31, 2024 $83.09M Mar 31, 2026
FY2024 Dec 31, 2023 $33.69M Mar 31, 2025
FY2023 Dec 31, 2022 $230.77M Apr 1, 2024
FY2022 Dec 31, 2021 $203.95M Sep 13, 2023

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $42.62M Mar 31, 2026
FY2025 Dec 31, 2024 $33.32M Mar 31, 2026
FY2024 Dec 31, 2023 $32.48M Mar 31, 2025
FY2023 Dec 31, 2022 $912.9K Apr 1, 2024
FY2022 Dec 31, 2021 $7.44M Sep 13, 2023

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2024 Dec 31, 2023 ($151.25M) Mar 31, 2025
FY2023 Dec 31, 2022 $163.3K Apr 1, 2024
FY2023 Dec 31, 2021 ($5.48M) Apr 1, 2024
FY2022 Feb 2, 2021 $0 Sep 13, 2023

Retained Earnings

Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 ($189.25M) Mar 31, 2026
FY2025 Dec 31, 2024 ($191.05M) Mar 31, 2026
FY2024 Dec 31, 2023 ($146.39M) Mar 31, 2025
FY2023 Dec 31, 2022 $162.7K Apr 1, 2024
FY2022 Dec 31, 2021 ($5.48M) Sep 13, 2023

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $31.83M Mar 31, 2026
FY2025 Dec 31, 2024 $28.33M Mar 31, 2026
FY2025 Dec 31, 2023 $6.76M Mar 31, 2026
FY2021 Dec 31, 2021 $875.8K Apr 8, 2022
FY2021 Feb 2, 2021 $0 Apr 8, 2022

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 0 Mar 31, 2026
FY2024 Dec 31, 2024 (4) Mar 31, 2025
FY2024 Dec 31, 2023 (1) Mar 31, 2025

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 0 Mar 31, 2026
FY2024 Dec 31, 2024 (4) Mar 31, 2025
FY2024 Dec 31, 2023 (1) Mar 31, 2025